NVAX

Novavax, Inc. Press Releases

$3.78
*  
0.09
 negative 
2.44%
Get NVAX Alerts
*Delayed - data as of Apr. 16, 2014 9:55 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NVAX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations
4/7/2014 12:33:00 PM - GlobeNewswire

Novavax to Present at the 13th Annual Needham Healthcare Conference
4/2/2014 4:10:00 PM - GlobeNewswire

Top Gainers at a Glance -- Research on Lions Gate Entertainment, Novavax, Glu Mobile, and Vipshop Holdings
4/1/2014 9:17:00 AM - PR Newswire

Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies
4/1/2014 8:00:00 AM - Business Wire

Appointments, Stock Price Updates, Acquisitions, Financial Results and Technology Deployments - Analyst Notes on Stryker, ArthroCare, Novavax, Cooper, and Varian
3/14/2014 8:00:00 AM - PR Newswire

Pre-Market Equity Coverage - Most Active: Comcast, America Movil, Novavax, and Real Goods Solar
3/12/2014 12:41:00 PM - PR Newswire

Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM)
3/10/2014 4:14:00 PM - GlobeNewswire

Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations
3/10/2014 8:30:00 AM - GlobeNewswire

New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara
3/5/2014 7:24:00 AM - PR Newswire

Novavax Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness With HHS-BARDA
2/27/2014 4:15:00 PM - GlobeNewswire

Novavax to Report Fourth Quarter and Year-End 2013 Financial Results on March 10, 2014
2/19/2014 4:28:00 PM - GlobeNewswire